Celmoleukin

西莫白介素

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCelmoleukin
Drug Alias NameIL-2 (Takeda)TGP-3Interleukin 2 (human clone pTIL2-21α protein moiety)Interleukin-2 (Takeda)Celeuk
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulantsInterleukin-2 receptor agonists
TargetsInterleukin-2 receptor
Therapy Area/IndicationsHemangiosarcoma
Global Approved IndicationsHemangiosarcoma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1992/05/22
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHemangiosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeL03AX
Related LinksN/A